Showing results (91-100 of 317) with videos related to

Sort By:
Pageof 32
Monatsschrift Fur Kinderheilkunde|March 1, 1978
[Beclomethasone dipropionate seasonal allergic rhinitis treatment of children. A double blind cross over study (author's transl)]U Wahn, W Rebien, E Stix, et al.
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|January 1, 1990
[Allergic reactions in treatment with L-asparaginase. Significance of specific IgE antibodies]D Körholz, U Wahn, H Jürgens, et al.
Mediators of Inflammation|January 1, 1995
Myeloperoxidase and eosinophil cationic protein in serum and sputum during antibiotic treatment in cystic fibrosis patients with Pseudomonas aeruginosa infectionB Niggemann, T Stiller, K Magdorf, et al.
Allergy|February 1, 1994
Twenty-four-hour time course of eosinophil granule proteins ECP and EPX during bronchial allergen challenges in serum of asthmatic childrenB Niggemann, I Kleinau, M Schmitt, et al.
Allergy|January 1, 1993
Monitoring of inflammation during challenge tests in childrenU Wahn, B Niggemann, I Kleinau, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 1, 2014
Positive reactions to placebo in children undergoing double-blind, placebo-controlled food challengeB Ahrens, B Niggemann, U Wahn, et al.
Allergy|July 1, 1982
Allergoprints in horse allergic childrenU Wahn, U Herold, K Danielsen, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|November 1, 1994
Increased Na+/Mg2+ antiport in erythrocytes of patients with cystic fibrosisJ Vormann, K Magdorf, T Günther, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 21, 2008
Pyrazinamide serum levels in childhood tuberculosisS Thee, A Detjen, U Wahn, et al.
The Journal of Allergy and Clinical Immunology|November 5, 1998
Latex provocation tests in patients with spina bifida: who is at risk of becoming symptomatic?B Niggemann, D Buck, T Michael, et al.
Pageof 32